Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats

By Gunther J.   Wagner K.-D.   Theres H.   Schimke I.   Born A.   Scholz H.   Vetter R.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy

By Yotsumoto T.   Naitoh T.   Kitahara M.   Tsuruzoe N.  

European Journal of Pharmacology, Vol. 398, Iss. 2, 2000-06 ,pp. : 297-302

Elsevier

Access to resources Recommend Favorite

Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure: Perspectives on a Shift in Myocardial Metabolism as a Therapeutic Intervention

By Sushma A. Mengi   Naranjan S. Dhalla  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 201-209

Adis International

Access to resources Recommend Favorite

Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris: A Sub-Study from TRIMPOL-1 (Trimetazidine in Poland)

By Kowalisko A.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Potent and selective inhibition of the human Na + /H + exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559

By Kawamoto T.   Kimura H.   Kusumoto K.   Fukumoto S.   Shiraishi M.   Watanabe T.   Sawada H.  

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite